Product Information
VIORELE 28 DAY TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.1610 per EA under NDC 68462031829. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Apr 2, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462031829
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA091346FDA Approved
4/2/2012
TE Code
AB
On Market Since
4/4/2012
Price Statistics
The NADAC for VIORELE 28 DAY TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 85.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1610 per EA |
|---|---|
| All-time high | $1.1046 (Mar 12, 2014) |
| All-time low | $0.1319 (Apr 17, 2024) |
| 52-week high | $0.2029 |
| 52-week low | $0.1493 |
| Median price | $0.4752 |
| Average price | $0.5089 |
| Largest weekly change | +42.3% (Nov 22, 2023) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VIORELE 28 DAY TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VIORELE 28 DAY TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.1610 per EA (NDC 68462031829), effective Aug 19, 2026.
How has the price of VIORELE 28 DAY TABLET changed over time?
Over the history we have for it, the NADAC for VIORELE 28 DAY TABLET has declined 85.3%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VIORELE 28 DAY TABLET?
Since Nov 28, 2013, the NADAC for VIORELE 28 DAY TABLET has ranged from a low of $0.1319 (Apr 17, 2024) to a high of $1.1046 (Mar 12, 2014), with a median of $0.4752 per EA.
Are there cheaper alternatives to VIORELE 28 DAY TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as VIORELE 28 DAY TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures VIORELE 28 DAY TABLET?
VIORELE 28 DAY TABLET (NDC 68462031829) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.